- Home
- ELDN vs DOYU Comparison
ELDN vs DOYU Comparison
Compare ELDN & DOYU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- DOYU
- Stock Information
- Founded
- ELDN 2004
- DOYU 2014
- Country
- ELDN United States
- DOYU China
- Employees
- ELDN N/A
- DOYU N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- DOYU Computer Software: Programming Data Processing
- Sector
- ELDN Health Care
- DOYU Technology
- Exchange
- ELDN Nasdaq
- DOYU Nasdaq
- Market Cap
- ELDN 288.5M
- DOYU 312.9M
- IPO Year
- ELDN N/A
- DOYU 2019
- Fundamental
- Price
- ELDN $4.09
- DOYU $15.70
- Analyst Decision
- ELDN Strong Buy
- DOYU Strong Sell
- Analyst Count
- ELDN 1
- DOYU 3
- Target Price
- ELDN $16.00
- DOYU $7.03
- AVG Volume (30 Days)
- ELDN 520.7K
- DOYU 193.2K
- Earning Date
- ELDN 11-12-2024
- DOYU 11-20-2024
- Dividend Yield
- ELDN N/A
- DOYU N/A
- EPS Growth
- ELDN N/A
- DOYU N/A
- EPS
- ELDN N/A
- DOYU N/A
- Revenue
- ELDN N/A
- DOYU $631,661,209.00
- Revenue This Year
- ELDN N/A
- DOYU N/A
- Revenue Next Year
- ELDN N/A
- DOYU N/A
- P/E Ratio
- ELDN N/A
- DOYU N/A
- Revenue Growth
- ELDN N/A
- DOYU N/A
- 52 Week Low
- ELDN $1.52
- DOYU $6.29
- 52 Week High
- ELDN $5.54
- DOYU $20.17
- Technical
- Relative Strength Index (RSI)
- ELDN 47.03
- DOYU 78.09
- Support Level
- ELDN $3.68
- DOYU $10.25
- Resistance Level
- ELDN $4.19
- DOYU $16.15
- Average True Range (ATR)
- ELDN 0.32
- DOYU 0.51
- MACD
- ELDN -0.04
- DOYU 0.56
- Stochastic Oscillator
- ELDN 31.54
- DOYU 92.37
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About DOYU DouYu International Holdings Limited ADS
DouYu International Holdings Ltd is a game-centric live streaming platform in China and a pioneer in the eSports value chain. The company operates its platform on both PC and mobile apps, through which users can enjoy immersive and interactive games and entertainment live streaming. It generates revenues through live streaming and advertisement.